Phase 1 Alzheimer s Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)

HealthyMild Cognitive ImpairmentAlzheimer s Disease

National Institute of Mental Health (NIMH)90 enrolled1 locationNCT07169630

Recruiting

Phase 1

Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study

Alzheimer s DiseaseFaecal Microbiota Transplantation (FMT)

University Hospital of North Norway10 enrolled1 locationNCT07332260